FDA NDC Directory · JSON-LD · Markdown

HepaGam B

NDC 49591-051 · PLASMA DERIVATIVE · INJECTION, SOLUTION

Generic nameHUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Labeler / ManufacturerKamada Ltd.
Marketing categoryBiologic License Application · App BLA125035
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsHUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN (312 [iU]/mL)
Marketing started20251001
Package count1

External sources

Source: openFDA. Public-domain (CC0).